首页> 外国专利> ATTENTION DEFICIT HYPERACTIVITY DISORDER MODEL MICE, METHOD TO EVALUATE EFFECTS OF PREVENTING AND ALLEVIATING ATTENTION DISORDER DISEASE USING MODEL MICE, AND COMPOSITION CONTAINING NON-SPECIFIC T-TYPE CALCIUM INHIBITOR TO PREVENT AND TREAT ATTENTION DISORDER DISEASE

ATTENTION DEFICIT HYPERACTIVITY DISORDER MODEL MICE, METHOD TO EVALUATE EFFECTS OF PREVENTING AND ALLEVIATING ATTENTION DISORDER DISEASE USING MODEL MICE, AND COMPOSITION CONTAINING NON-SPECIFIC T-TYPE CALCIUM INHIBITOR TO PREVENT AND TREAT ATTENTION DISORDER DISEASE

机译:注意力缺陷多动障碍模型小鼠,使用模型小鼠评估预防和缓解注意力障碍疾病的效果的方法,以及包含非特异性T型钙抑制剂预防和治疗注意力障碍疾病的成分

摘要

The present invention relates to an attention deficit hyperactivity disorder model mouse and a method to screen a composition to prevent and treat attention disorder disease using the model mouse. More specifically, it can be found that: an animal model wherein a cobalt wire is inserted in the right side frontal lobe is useful as an attention deficit hyperactivity disorder model mouse; the attention deficit hyperactivity disorder model mouse can be applied to screen a therapeutic agent for attention disorder from the result obtained by administrating to the animal model ethosuximide, which is one of a non-specific T-type calcium channel inhibitors, showing brainwave having low frequency, hyperactivity, and decline in cognition which are characteristic of attention disorder; and a composition containing a non-specific T-type calcium channel inhibitor which can be useful to prevent and treat attention disorder.;COPYRIGHT KIPO 2015
机译:本发明涉及注意力缺陷多动障碍模型小鼠和使用该模型小鼠筛选预防和治疗注意力障碍疾病的组合物的方法。更具体地,发现:在右侧额叶中插入钴线的动物模型可用作注意力缺陷多动障碍模型小鼠。注意力缺陷多动障碍模型小鼠可以应用于从通过向动物模型中施用非特异的T型钙通道抑制剂之一的ethosuximide所获得的结果中筛选出注意力障碍的治疗剂,该药物显示出低频的脑电波注意力不集中的特征是:多动症和认知能力下降;含有非特异性T型钙通道抑制剂的组合物,可用于预防和治疗注意力障碍。; COPYRIGHT KIPO 2015

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号